Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OGN
OGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OGN News
Organon Receives FDA Approval for TOFIDENCE New Indications
Jun 10 2026
Newsfilter
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
Jun 10 2026
Globenewswire
Investor Alert: Investigations into Multiple Mergers
Jun 09 2026
Globenewswire
Pharmaceutical Giants Accelerate Acquisitions to Offset Patent Cliffs
Jun 05 2026
stocktwits
Organon to Present New Research Findings at ISPOR 2026
May 15 2026
Newsfilter
Investor Rights Law Firm Investigates Multiple Companies
May 14 2026
PRnewswire
Investigations into Multiple Company Acquisitions
May 14 2026
Globenewswire
Investor Rights Law Firm Investigates Multiple Companies
May 07 2026
Globenewswire
Investor Rights Law Firm Investigates Multiple Companies
May 05 2026
Globenewswire
Investigation Alerts for Multiple Company Mergers
May 05 2026
Globenewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
May 04 2026
PRnewswire
Organon Q1 Earnings Miss Expectations Amid Merger Talks
Apr 30 2026
seekingalpha
Organon Reports 4% Revenue Decline in Q1 2026
Apr 30 2026
Newsfilter
India's IT Sector Faces Employment Crisis Amid AI Disruption
Apr 30 2026
CNBC
EU Grants Marketing Authorization for POHERDY® Biosimilar
Apr 29 2026
PRnewswire
Henlius Receives EU Approval for POHERDY® Biosimilar
Apr 29 2026
Newsfilter
Show More News
